- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Daiichi Sankyo, Inc. (New York, NY)
- …primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: The Oncology ... hospitals, and community practices).Demonstrate understanding of current or pending clinical pathways in assigned accounts, and how they influence patient… more
- Merck & Co. (Rahway, NJ)
- …colleagues in Translational Medicine, as well as Discovery Sciences and late-stage Clinical Research while developing and expanding your career.This role will ... Translational Medicine-EU, Drug Metabolism/Modeling & Simulation, Regulatory Affairs, and late-stage Clinical Research throughout sites in the USA, UK and… more
- Eisai, Inc (Nutley, NJ)
- …and confidence in discussing drug information/ disease state management. Prior experience in clinical research , drug development and/or clinical pharmacy and ... clinical practice issues that may be uncovered as part of a field insights observation and analysis. Actively...of overall experience in Oncology with relevant combination industry/ clinical / research / academia; at least 5 years… more
- Merck & Co. (Rahway, NJ)
- …clinical development across all therapeutic areas and all phases of clinical development at our company's Research Laboratories. Translational Molecular ... the development, analytical validation, and testing of histopathology-based assays for clinical implementation and advancing digital pathology within our company's … more
- Merck & Co. (Rahway, NJ)
- …and Scientific Affairs (GMSA) portion for their assigned Therapeutic Areas (TA) as part of the Global Value & Implementation (V&I) Plans. -As a highly specialized ... which includes additional organizationally aligned responsibilities.- The GDMA works as part of a high-performing, results driven team, focused on executional… more
- Merck & Co. (Rahway, NJ)
- Job Description Sr. Scientist, Small Molecule Analytical Research & Development The Small Molecule Analytical Research and Development group has an opening for a ... human health through innovative drug delivery technologies and predictive analytical tools. As part of our global team, you will have the opportunity to collaborate… more
- Merck & Co. (Rahway, NJ)
- Job Description Position Description The Chemical Engineering Research & Development department (CERD), part of the Process Research and Development ... processes that deliver desired solid-state properties, purity, and yield for clinical programs across our diverse pipeline. This role involves the development… more
- Merck & Co. (Rahway, NJ)
- …Chemical Engineering Research & Development d epartment ( CERD ) , part of the Process Research and Development organization, is seeking highly motivated ... direction , an engineer in this role conducts independent research which involves conceiving, designing, planning, and implementing advanced experiments… more
- Merck & Co. (Rahway, NJ)
- …and execute design verification strategies that successfully supports the clinical instruction(s) and commercial market approval(s) of combination products.Principal ... strategies for assigned drug-device combination product program(s) for successful clinical introduction(s) and commercial market(s) approval(s).Define design input(s)/ output(s)… more
